Abstract
Mitochondrial diseases are a heterogeneous group of disorders in which a primary mitochondrial dysfunction is proven by morphological, biochemical, and genetic examinations. The mitral valve has important function in the regulation of blood flow from one chamber to another. Often, the mitral valve becomes abnormal with age, in Rheumatic fever or it is abnormal from birth (Congenital) or it can be destroyed by infection i.e. bacterial endocarditis and needs replacement. Myocardial function depends on energy produced by mitochondria and in any of these disease conditions, mitochondrial functions and enzyme activities may be impaired. With this in view, we analyzed the relationship between preoperative clinical conditions (as per New York heart Association) and extent of mitochondrial enzyme activities in damaged Human mitral valve in two types of heart disease such as Rheumatic Heart Disease (RHD) and Bacterial Endocarditis (BE). Thirty nine Patients undergoing cardiopulmonary bypass (CPB) for routine valvular heart surgery were included in the study. Controls included 11 normal porcine mitral valve samples without any evidence of heart disease. Mitochondrial enzymes like cytochrome oxidase (COX), succinate dehydrogenase (SDH), malate dehydrogenase (MDH), citrate synthase (CS) and ATPase were determined. Mitochondrial COX, SDH, CS and Total ATPase activities were significantly decreased in disease condition like BE and RHD when compared with control (P<0.001). On the other hand as per New York Heart Association (NYHA) preoperative clinical classification, all the mitochondrial enzymes were significantly (p<0.05) impaired in class IV as compared with NYHA class I, II and III. Present study shows that impairment in the mitochondrial enzymes activities are more pronounced in bacterial endocarditis (BE). It also indicates that damage to mitochondrial enzymes are most pronounced in NYHA class IV.
Similar content being viewed by others
References
Henry, G. (1985) Anatomy of the Human Body. In: carmine d.clemente (eds), The Heart, 606.
Carvajal, K. and Moreno-Sanchez, R. (2003) Heart metabolic disturbances in cardiovascular diseases. Arch Med Res. 34(2), 89–99.
Fritiof, S., Bradley, S.A. and Gerald, D. B. (1986) Studies of controlled reperfusion after ischemia. J Cardiovascular Surg. 92, 513–524.
Oliveira, H.C., Cosso, R.G. and Alberici, L.C. (2005) Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria. FASEB J. 19(2), 278–280.
Schwartz, A. and Lee, K.S. (1962) Study of heart mitochondria and glycolyticmetabolism in experimentally induced cardiac failure. Circulat Res. 10, 321.
Argus, M.F. and Arcos, J.C. (1964) Oxidative rates and phosphorylation in sarcosome from experimentally induced failing rat heart. Proc. Soc. Exp. Biol. (N.Y.) 117, 380.
Mangano, D. T. (1999) Preoperative assessment of cardiac risk. Kaplan J A. Cardiac Anesthesia. Philadelphia: W B Saunders Company, 9.
Morrow, A.G. and Clark, W.D. (1964) Prosthetic replacement of the mitral valve. Operative methods and the results of preoperative and postoperative hemodynamic assessments. Circulation 29, 2.
Tyler, D.D. and Jeanine, G. (1967) The preparation of heart mitochondrial from laboratory animal. In: rnald westabrook (eds) Methods in Enzymology Vol. X, 75.
Veeger, C. and Dervartanian, D. V. (1969) Succinate Dehydrogenase (E.C. 1.3.99.1). In: Methods in Enzymology, Vol. XIII. JOHN M LOWENSTEIN (eds), Academic press, New York, pp 3–10.
Asati, T. (1973) Regulatory function of MDH Isoenzymes in cotyledons of mung bean. J Biochem. 73, 217.
Srere, P.A. (1969) Citrate Synthase (EC 4.1.3.7). In: John M Lowenstein (eds), Methods in Enzymology, vol. XIII. Academic press, New York: 3–10.
Smith, L. (1955) Spectroscopic assay of cytochrome oxidase. Methods Biochem. Anal. 2, 427–434.
Fiske and Subbarow (1925) The colorimetric determination of phosphorus. J. Biol. Chem. 66, 375–400.
Lowry, O. H. and Rosenburg, M. Y. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265–275.
Jeanne, M.R. and Chin-Hua, W. (1989) Scanning electron microscopy of surgically excised human mitral valves in patients over 45 years of age. Am. J. Cardiol. 63, 471–477.
Opie, L. H. (1997) Normal and abnormal Circulatory Function. In: Heart Disease. vol 1. BRAUNWALD (eds), W B Saunders Company: 360.
Racker, E. (1961) Mechanisms of synthesis of adenosine triphosphate (ATP). Advanc. Enzymol. 23, 323.
James, J. K. (1975) Mitochondrial function, Oxygen extraction, epicardial S-T segment changes and tritiated digoxin distribution after reperfusion of ischemic myocardium. Am. J. Cardiol. 36, 218–224.
Maliuk, V.I. and Tsyganii, A.A. (1976) Cytochrome system of myocardial mitochondrial in patients with mitral valve insufficiency. Kardiologiia 16, 89–94.
VITI. (1968) Cytochrome C in dipheric intoxication. Pathologica. 60, 213.
Drahota, Z. and Milerova, M. (2004) Development changes of cytochrome c Oxidase and citrate synthase in rat heart homogenate. Physiol. Res. 53, 119–122.
Szekeres, L. (1959) Cell metabolism of the overloaded mammalian heart in situ. Cardiologia 34, 18–27.
Gertler (1961) Difference in efficiency of energy transfer in mitochondrial systems derived from normal and failure heart. Proc. Soc. Exp. Biol. Med. 106, 109–112.
Bing, R.J. (1964) Mechanism of heart failure. Cir. Res. 15 (2), 64–68.
Wollenberger, A. and Raabe, G. (1963) Some metabolic characteristics of mitochondria from chronically overloaded, hypertrophied hearts. Exp. Molec. Path. 2, 251–260.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shinde, S., Kumar, P., Mishra, K. et al. Defect in mitochondrial functions in damaged human mitral valve. Indian J Clin Biochem 21, 156–160 (2006). https://doi.org/10.1007/BF02912933
Issue Date:
DOI: https://doi.org/10.1007/BF02912933